Novartis Announces Increased Investment in China, Plans to Invest Over 3.3 Billion Yuan

2026-03-22 23:25:36

The China Development High-Level Forum 2026 Annual Conference was grandly opened in Beijing. During the event, Novartis announced that it will continue to increase its investment in China, expanding its research, development, manufacturing, and operational footprint in the country. The company is expected to invest over 3.3 billion RMB to support innovation and high-quality development in China’s biopharmaceutical industry. (Jiemian News)

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes